As the “triple-demic” of COVID-19, influenza, and respiratory syncytial virus raged through the fall and winter, drug manufacturers found themselves unable to keep up with increased demand for children’s liquid ibuprofen and other liquid pain relievers and fever reducers.
Sonya Collins